Walter Ageno Selected Research

Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)

8/2022	Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial.
1/2022	Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study.
11/2021	Cancer-Associated Splanchnic Vein Thrombosis.
5/2021	Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study.
10/2020	Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis.
1/2020	The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis.
1/2019	Anticoagulation After Stroke in Patients With Atrial Fibrillation.
8/2018	Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance.
2/2018	European guidelines on perioperative venous thromboembolism prophylaxis: Intensive care.
6/2017	Subgroup Analysis of Patients with Cancer in XALIA: A Noninterventional Study of Rivaroxaban versus Standard Anticoagulation for VTE.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Walter Ageno Research Topics

Disease

126	Venous Thromboembolism 10/2022 - 01/2000
121	Hemorrhage 10/2022 - 01/2000
53	Thrombosis (Thrombus) 02/2022 - 12/2005
44	Venous Thrombosis (Deep-Vein Thrombosis) 02/2022 - 01/2003
43	Atrial Fibrillation 01/2022 - 02/2007
41	Neoplasms (Cancer) 05/2022 - 06/2005
39	Pulmonary Embolism 02/2022 - 07/2003
33	Stroke (Strokes) 01/2022 - 01/2001
17	Ischemic Stroke 07/2022 - 12/2002
16	Thromboembolism 01/2022 - 01/2005
12	COVID-19 08/2022 - 01/2020
10	Embolism (Embolus) 10/2022 - 10/2004
10	Thrombocytopenia (Thrombopenia) 01/2022 - 03/2004
6	Acute Coronary Syndrome 06/2022 - 03/2005
6	Renal Insufficiency (Renal Failure) 06/2021 - 01/2008
5	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 04/2007
4	Hypertension (High Blood Pressure) 01/2022 - 07/2012
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2021 - 01/2013
4	Thrombophilia 08/2014 - 01/2005
3	Inflammation (Inflammations) 01/2022 - 08/2011
3	Infections 01/2022 - 08/2011
3	Atherosclerosis 06/2021 - 10/2010
3	Embolic Stroke 06/2021 - 08/2015
3	Heart Failure 06/2021 - 01/2005
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 05/2021 - 08/2018
3	Lung Neoplasms (Lung Cancer) 10/2020 - 03/2008
3	Hematoma 01/2020 - 08/2008
3	Fibrosis (Cirrhosis) 01/2018 - 02/2014
3	Retinal Vein Occlusion 09/2010 - 09/2007
2	Critical Illness (Critically Ill) 08/2022 - 02/2018
2	Uterine Hemorrhage (Uterine Bleeding) 08/2022 - 01/2021
2	Vascular Diseases (Vascular Disease) 01/2022 - 02/2014
2	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2017
2	Hemophilia A (Haemophilia) 07/2021 - 05/2007
2	Liver Cirrhosis (Hepatic Cirrhosis) 07/2021 - 09/2008
2	Chronic Obstructive Pulmonary Disease (COPD) 06/2021 - 01/2003
2	Disease Progression 05/2021 - 01/2021
2	Drug-Related Side Effects and Adverse Reactions 01/2021 - 11/2018
2	Cerebral Hemorrhage 01/2021 - 01/2020
2	Body Weight (Weight, Body) 11/2020 - 09/2016
2	Myocardial Ischemia (Ischemic Heart Diseases) 08/2019 - 02/2014
2	Osteoporosis 11/2018 - 03/2004
2	Hepatic Insufficiency 11/2018 - 12/2015
2	Liver Diseases (Liver Disease) 01/2018 - 05/2007

Drug/Important Bio-Agent (IBA)

150	AnticoagulantsIBA 08/2022 - 08/2002
55	Vitamin K FDA Link 01/2022 - 07/2004
30	RivaroxabanIBA 10/2022 - 06/2008
28	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2000
26	Warfarin (Coumadin)FDA LinkGeneric 07/2021 - 08/2002
25	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 08/2022 - 01/2001
15	Enoxaparin (Lovenox)FDA LinkGeneric 10/2022 - 01/2005
14	fibrin fragment D (D-dimer)IBA 01/2021 - 12/2002
13	Pharmaceutical PreparationsIBA 10/2022 - 01/2001
10	edoxabanIBA 05/2022 - 05/2016
10	Dabigatran FDA Link 01/2022 - 01/2013
10	Factor Xa InhibitorsIBA 01/2021 - 01/2005
7	apixabanIBA 01/2022 - 01/2013
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2015 - 07/2008
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2001
6	Fondaparinux (Arixtra)FDA Link 07/2017 - 01/2005
5	Biomarkers (Surrogate Marker)IBA 06/2022 - 07/2004
5	Dalteparin (Dalteparin Sodium)FDA Link 05/2022 - 01/2005
5	CreatinineIBA 10/2021 - 12/2015
5	AntithrombinsIBA 05/2015 - 01/2005
4	pro-brain natriuretic peptide (1-76)IBA 06/2022 - 04/2009
4	betrixabanIBA 02/2020 - 05/2018
4	Blood Group Antigens (Blood Groups)IBA 08/2014 - 07/2012
4	Prothrombin (Factor II)IBA 07/2013 - 01/2005
3	C-Reactive ProteinIBA 01/2021 - 10/2011
3	Thrombin FDA Link 11/2018 - 03/2016
3	ABO Blood-Group SystemIBA 08/2014 - 02/2013
2	COVID-19 VaccinesIBA 08/2022 - 08/2021
2	TroponinIBA 06/2022 - 01/2022
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 08/2019
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2008
2	Fibrinogen (Factor I)FDA Link 07/2021 - 12/2020
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2021 - 10/2008
2	cupric sulfide (CuS)IBA 12/2020 - 01/2010
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2020 - 01/2001
2	LDL CholesterolIBA 01/2018 - 09/2009
2	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2016 - 04/2009
2	Nadroparin (Nadroparin Calcium)IBA 07/2016 - 01/2003

Therapy/Procedure

80	Therapeutics 02/2022 - 08/2002
11	Secondary Prevention 01/2022 - 07/2008
6	Contraindications 01/2022 - 04/2012
5	Knee Replacement Arthroplasty (Total Knee Replacement) 12/2021 - 06/2008
5	Thrombolytic Therapy 01/2020 - 04/2015
4	Drug Therapy (Chemotherapy) 09/2020 - 12/2014
4	Catheters 01/2016 - 06/2005
3	Orthopedic Procedures 01/2022 - 06/2009
3	Length of Stay 01/2022 - 08/2017
3	Drug Tapering 01/2022 - 09/2016
3	Vena Cava Filters (Inferior Vena Cava Filter) 01/2019 - 02/2008
3	Duration of Therapy 01/2019 - 07/2003
2	Polypharmacy 06/2021 - 01/2018
2	Central Venous Catheters 08/2019 - 09/2007
2	Operative Surgical Procedures 12/2018 - 10/2006
2	Stents 12/2018 - 10/2018
2	Percutaneous Coronary Intervention 10/2018 - 10/2011
2	Anticoagulation Reversal 11/2016 - 09/2011